Prelude Fertility was founded in late 2016 by successful startup entrepreneur Martin Varsavsky with a $200M investment. Source: BioSpace

The Company previously completed a seed round fundraising in 2008 concurrent with its founding. Source: BioSpace

Pfizer will use Arvinas' proprietary PROTAC Platform to create small molecule therapeutics aimed at degrading disease-causing cellular proteins. Source: BioSpace

OvaScience provided a corporate update that includes initial data from a Phase I trial and news of extensive layoffs. Source: BioSpace

The Series A financing was co-led by 5AM Ventures, OrbiMed Advisors and venBio Partners. Source: BioSpace

Generation Bio is developing a breakthrough class of genetic medicines based on its proprietary GeneWave technology Source: BioSpace

A Novartis drug approved as a second-line treatment for a blood disorder snagged the FDA's Breakthrough Therapy Designation as a first-line defense. Source: BioSpace

The funds will be used to expand its growing pipeline and progress several early stage molecules towards the clinic. Source: BioSpace

Sangamo and Pfizer will use the company's ZFP-TFs to develop the treatments that are linked to mutations of the C9ORF72 gene, which can cause both ALS and FTLD. Source: BioSpace

The therapy is the first type approved by the FDA that targets a disease caused by mutations in a specific gene. Source: BioSpace